Deep Dives

Auto Added by WPeMatico

Banner for the AI & Big Data Expo event series.

PRISM2 model uses clinical dialogue to interpret pathology slides

Built by Paige and Microsoft, PRISM2 reads whole-slide images through a perceiver-based encoder trained jointly on tissue tiles and clinical dialogue drawn from pathology reports. The model aggregates thousands of tile embeddings per slide into one representation, then generates text that answers diagnostic questions rather than simply classifying pixels.  Training data spans 2.3 million whole-slide […]

PRISM2 model uses clinical dialogue to interpret pathology slides Read More »

Banner for AI & Big Data Expo by TechEx events.

Why biological data matters more in AI drug discovery

GSK has entered into a research collaboration with British biotechnology company Relation Therapeutics worth up to $110 million, expanding the companies’ existing work in AI-assisted drug discovery. Under the agreement, Relation will generate large-scale datasets measuring how human cells respond to genetic changes and drug interventions. The data will be used to train AI models

Why biological data matters more in AI drug discovery Read More »

Banner for the AI & Big Data Expo event series.

Google’s Gemini 3.6 Flash targets enterprise agent token costs

Google has released Gemini 3.6 Flash and 3.5 Flash-Lite as new workhorses designed to cut latency and token costs for enterprise AI agents. The economics of running autonomous software agents inside a production environment come down to a fixed equation few vendors advertise directly. A model needs to reason through a multi-step task competently, but

Google’s Gemini 3.6 Flash targets enterprise agent token costs Read More »

Banner for the AI & Big Data Expo event series.

Chinese open-weight models are cheap. Washington is deciding what that costs.

Enterprises evaluating Chinese open-weight models this month face a question that has nothing to do with benchmarks: whether using one will still be straightforward in a year. Moonshot AI’s Kimi K3 arrived on July 16 as the largest open-weight model yet released, and within days it had reopened a policy argument in Washington that had

Chinese open-weight models are cheap. Washington is deciding what that costs. Read More »

Kimi K3 open-weight model: China’s biggest AI is a bet on memory, not compute

Moonshot AI’s Kimi K3 open-weight model has been read almost entirely through its parameter count since it launchedon July 16. At 2.8 trillion parameters, it is the largest open-weight model released to date. Model sizes are usually grouped into rough brackets, and 2.8 trillion rounds into what the industry calls the 3T class. A tier no

Kimi K3 open-weight model: China’s biggest AI is a bet on memory, not compute Read More »

Banner for the AI & Big Data Expo event series.

Examining Google DeepMind’s AI bioresilience push

Google DeepMind and Isomorphic Labs outlined a bioresilience program to curb AI misuse in biology while aiding outbreak response. The two organisations published an update on a joint initiative that began quietly and has now built out more than 15 partnerships with government bodies, biosecurity organisations, and research groups over the past 12 months. The

Examining Google DeepMind’s AI bioresilience push Read More »

Banner for the AI & Big Data Expo event series.

AWS and Bluesight build AI for hospital 340B compliance

AWS (Amazon Web Services) has explained how Bluesight developed Prism, an AI layer that connects hospital pharmacy and compliance data across its product suite. Prism Assistant for ControlCheck has reached general availability and operates across 20 health systems, according to AWS vendor statements. Meanwhile, a multi-product agent for 340B Group Purchasing Organisation (GPO) compliance remains

AWS and Bluesight build AI for hospital 340B compliance Read More »

Banner for the AI & Big Data Expo event series.

Insilico Medicine advances AI drug for IPF to Phase III trials

Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients

Insilico Medicine advances AI drug for IPF to Phase III trials Read More »

Banner for AI & Big Data Expo by TechEx events.

NVIDIA BioNeMo accelerates Anthropic Claude Science

Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to accelerate computational life sciences research. Anthropic has launched the public beta of Claude Science, an AI workbench built for scientific research. The platform enables scientists to converse directly with digital agents using natural language to execute end-to-end research workflows. This system connects natively to

NVIDIA BioNeMo accelerates Anthropic Claude Science Read More »

Banner for the AI & Big Data Expo event series.

Deploying retail AI to scale personalisation and customer insight

Optimising retail AI infrastructure drives the successful deployment of personalisation systems and real-time customer insight. Leaders are replacing static customer interaction patterns with data pipelines capable of modifying the user environment during a live session. Static layouts and broad segmentation rules fail to satisfy modern conversion targets. Deployments demonstrate that traditional demographic categorisation generates insufficient

Deploying retail AI to scale personalisation and customer insight Read More »